Trial in Adult Participants With Spinocerebellar Ataxia (SCA)

NCT02960893 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinocerebellar Ataxias
Spinocerebellar Ataxia Genotype Type 1
Spinocerebellar Ataxia Genotype Type 2
Spinocerebellar Ataxia Genotype Type 3
Spinocerebellar Ataxia Genotype Type 6
Spinocerebellar Ataxia Genotype Type 7
Spinocerebellar Ataxia Genotype Type 8
Spinocerebellar Ataxia Genotype Type 10

Interventions

DRUG: Troriluzole
DRUG: Placebo
DRUG: Troriluzole

Sponsor

Biohaven Pharmaceuticals, Inc.